ALC
Price
$85.42
Change
+$1.30 (+1.55%)
Updated
Aug 7, 04:59 PM (EDT)
Capitalization
40.86B
13 days until earnings call
VERO
Price
$2.41
Change
-$0.04 (-1.63%)
Updated
Aug 7, 04:59 PM (EDT)
Capitalization
4.45M
Interact to see
Advertisement

ALC vs VERO

Header iconALC vs VERO Comparison
Open Charts ALC vs VEROBanner chart's image
Alcon
Price$85.42
Change+$1.30 (+1.55%)
Volume$8.84K
Capitalization40.86B
Venus Concept
Price$2.41
Change-$0.04 (-1.63%)
Volume$168
Capitalization4.45M
ALC vs VERO Comparison Chart in %
Loading...
ALC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VERO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALC vs. VERO commentary
Aug 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALC is a Buy and VERO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 08, 2025
Stock price -- (ALC: $84.12 vs. VERO: $2.45)
Brand notoriety: ALC and VERO are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: ALC: 131% vs. VERO: 1%
Market capitalization -- ALC: $40.86B vs. VERO: $4.45M
ALC [@Medical Specialties] is valued at $40.86B. VERO’s [@Medical Specialties] market capitalization is $4.45M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.69B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALC’s FA Score shows that 0 FA rating(s) are green whileVERO’s FA Score has 0 green FA rating(s).

  • ALC’s FA Score: 0 green, 5 red.
  • VERO’s FA Score: 0 green, 5 red.
According to our system of comparison, VERO is a better buy in the long-term than ALC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALC’s TA Score shows that 4 TA indicator(s) are bullish while VERO’s TA Score has 3 bullish TA indicator(s).

  • ALC’s TA Score: 4 bullish, 6 bearish.
  • VERO’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, ALC is a better buy in the short-term than VERO.

Price Growth

ALC (@Medical Specialties) experienced а -5.67% price change this week, while VERO (@Medical Specialties) price change was -7.20% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.65%. For the same industry, the average monthly price growth was -1.54%, and the average quarterly price growth was -3.32%.

Reported Earning Dates

ALC is expected to report earnings on Aug 20, 2025.

Industries' Descriptions

@Medical Specialties (+0.65% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALC($40.9B) has a higher market cap than VERO($4.45M). ALC YTD gains are higher at: -0.907 vs. VERO (-40.843). ALC has higher annual earnings (EBITDA): 2.24B vs. VERO (-26.29M). ALC has more cash in the bank: 1.1B vs. VERO (4.93M). VERO has less debt than ALC: VERO (83.9M) vs ALC (5.14B). ALC has higher revenues than VERO: ALC (9.46B) vs VERO (82.5M).
ALCVEROALC / VERO
Capitalization40.9B4.45M919,308%
EBITDA2.24B-26.29M-8,529%
Gain YTD-0.907-40.8432%
P/E Ratio41.85N/A-
Revenue9.46B82.5M11,461%
Total Cash1.1B4.93M22,351%
Total Debt5.14B83.9M6,120%
FUNDAMENTALS RATINGS
ALC vs VERO: Fundamental Ratings
ALC
VERO
OUTLOOK RATING
1..100
6565
VALUATION
overvalued / fair valued / undervalued
1..100
69
Overvalued
35
Fair valued
PROFIT vs RISK RATING
1..100
48100
SMR RATING
1..100
83100
PRICE GROWTH RATING
1..100
7664
P/E GROWTH RATING
1..100
72100
SEASONALITY SCORE
1..100
985

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VERO's Valuation (35) in the null industry is somewhat better than the same rating for ALC (69) in the Hospital Or Nursing Management industry. This means that VERO’s stock grew somewhat faster than ALC’s over the last 12 months.

ALC's Profit vs Risk Rating (48) in the Hospital Or Nursing Management industry is somewhat better than the same rating for VERO (100) in the null industry. This means that ALC’s stock grew somewhat faster than VERO’s over the last 12 months.

ALC's SMR Rating (83) in the Hospital Or Nursing Management industry is in the same range as VERO (100) in the null industry. This means that ALC’s stock grew similarly to VERO’s over the last 12 months.

VERO's Price Growth Rating (64) in the null industry is in the same range as ALC (76) in the Hospital Or Nursing Management industry. This means that VERO’s stock grew similarly to ALC’s over the last 12 months.

ALC's P/E Growth Rating (72) in the Hospital Or Nursing Management industry is in the same range as VERO (100) in the null industry. This means that ALC’s stock grew similarly to VERO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALCVERO
RSI
ODDS (%)
Bearish Trend 2 days ago
61%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
64%
Bullish Trend 2 days ago
88%
Momentum
ODDS (%)
Bearish Trend 2 days ago
50%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
50%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
49%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
45%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 16 days ago
59%
Bullish Trend 15 days ago
86%
Declines
ODDS (%)
Bearish Trend 2 days ago
57%
Bearish Trend 10 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
56%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
44%
Bearish Trend 2 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
ALC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VERO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
EALT33.310.20
+0.60%
Innovator U.S. Equity 5 To 15 Buf ETF-Qt
ITDG35.070.21
+0.60%
iShares LifePath Target Date 2055 ETF
IBDR24.180.01
+0.04%
iShares iBonds Dec 2026 Term Corp ETF
TVAL32.690.01
+0.03%
T. Rowe Price Value ETF
PQJA27.15N/A
N/A
PGIM NASDAQ-100 BUFFER 12 ETF - JANUARY

ALC and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALC has been loosely correlated with A. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if ALC jumps, then A could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALC
1D Price
Change %
ALC100%
-1.66%
A - ALC
54%
Loosely correlated
-1.44%
SYK - ALC
54%
Loosely correlated
-1.55%
DHR - ALC
53%
Loosely correlated
-1.94%
TMO - ALC
53%
Loosely correlated
-3.75%
COO - ALC
51%
Loosely correlated
-2.07%
More

VERO and

Correlation & Price change

A.I.dvisor indicates that over the last year, VERO has been loosely correlated with ISRG. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if VERO jumps, then ISRG could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VERO
1D Price
Change %
VERO100%
-1.61%
ISRG - VERO
35%
Loosely correlated
-0.62%
CRL - VERO
34%
Loosely correlated
-10.25%
ANSLY - VERO
33%
Loosely correlated
N/A
ALC - VERO
31%
Poorly correlated
-1.66%
ESTA - VERO
30%
Poorly correlated
-5.09%
More